annahero.blogg.se

Parallax volatility advisers regulatory filings
Parallax volatility advisers regulatory filings







parallax volatility advisers regulatory filings parallax volatility advisers regulatory filings

(NASDAQ:BIOS – Get Rating) was the target of a large drop in short interest in December. (NASDAQ:BIOS) Decreases By 53.3%īioPlus Acquisition Corp. Short Interest in BioPlus Acquisition Corp. As of December 30th, there was short interest totalling 1,20 (NASDAQ:BIOS – Get Rating) was the recipient of a large decrease in short interest during the month of December. (NASDAQ:BIOS) Decreases By 14.3%īioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC Makes New Investment in BioPlus Acquisition Corp. As of March 31st, there was short interest totalling 4,300 shares, a decrease of 18.9% from the M (NASDAQ:BIOS – Get Rating) saw a large decrease in short interest in March. (NASDAQ:BIOS) Declines By 18.9%īioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) by 31.7% in the 4th quarter, according to the company in its most recent Form 13F filing with (NASDAQ:BIOS)īank of Montreal Can lessened its stake in shares of BioPlus Acquisition Corp. Transaction values Avertix at an enterprise value of $195 million- Avertix developed the Guardian System, the first and only FDA-approved solution designed to detect and warn patients of cardiac eveīank of Montreal Can Trims Stock Holdings in BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) by 60.0% in the fourth quarter, according to its most recent disclosure with the SEĪvertix, Maker Of Only FDA-Approved Implantable Heart Attack Warning System, To Become Publicly Traded Via Merger With BIOS Acquisition Corporation lowered its stake in shares of BioPlus Acquisition Corp. Has $103,000 Stake in BioPlus Acquisition Corp. SPAC BIOS to Merge With Cardiac Device Maker Avertix REGULATED INFORMATION Mont-Saint-Guibert, Belgium, June 1st, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the innovative company addressing unmet medical needs in in the areas of Avertix's Guardian System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth OrlandoīioSenic SA : Information on the Total Number of Voting Rights and Shares









Parallax volatility advisers regulatory filings